ReviewMedical oncology (Northwood, London, England)2025

Targeting exon mutations in NSCLC: clinical insights into LAG-3, TIM-3 pathways, and advances in fourth-generation EGFR-TKIs.

Koteeswaran Kannan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.